Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Am J Trop Med Hyg ; 109(5): 1118-1121, 2023 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-37722664

RESUMO

There is a knowledge gap in the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) causing bloodstream infections (BSIs) in Peru. Through a surveillance study in 13 hospitals of 10 Peruvian regions (2017-2019), we assessed the proportion of MRSA among S. aureus BSIs as well as the molecular typing of the isolates. A total of 166 S. aureus isolates were collected, and 36.1% of them were MRSA. Of note, MRSA isolates with phenotypic and genetic characteristics of the hospital-associated Chilean-Cordobes clone (multidrug-resistant SCCmec I, non-Panton-Valentine leukocidin [PVL] producers) were most commonly found (70%), five isolates with genetic characteristics of community-associated MRSA (CA-MRSA)-SCCmec IV, PVL-producer-(8.3%) were seen in three separate regions. These results demonstrate that hospital-associated MRSA is the most frequent MRSA found in patients with BSIs in Peru. They also show the emergence of S. aureus with genetic characteristics of CA-MRSA. Further studies are needed to evaluate the extension of CA-MRSA dissemination in Peru.


Assuntos
Infecções Comunitárias Adquiridas , Staphylococcus aureus Resistente à Meticilina , Sepse , Infecções Estafilocócicas , Humanos , Staphylococcus aureus Resistente à Meticilina/genética , Staphylococcus aureus/genética , Peru/epidemiologia , Infecções Estafilocócicas/epidemiologia , Infecções Comunitárias Adquiridas/epidemiologia , Exotoxinas/genética , Leucocidinas/genética , Testes de Sensibilidade Microbiana , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico
2.
Am J Trop Med Hyg ; 109(5): 1095-1106, 2023 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-37722663

RESUMO

Surveillance of antimicrobial resistance among gram-negative bacteria (GNB) is of critical importance, but data for Peru are not available. To fill this gap, a non-interventional hospital-based surveillance study was conducted in 15 hospitals across Peru from July 2017 to October 2019. Consecutive unique blood culture isolates of key GNB (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter spp.) recovered from hospitalized patients were collected for centralized antimicrobial susceptibility testing, along with linked epidemiological and clinical data. A total of 449 isolates were included in the analysis. Resistance to third-generation cephalosporins (3GCs) was present in 266 (59.2%) GNB isolates. Among E. coli (n = 199), 68.3% showed 3GC resistance (i.e., above the median ratio for low- and middle-income countries in 2020 for this sustainable development goal indicator). Carbapenem resistance was present in 74 (16.5%) GNB isolates, with wide variation among species (0% in E. coli, 11.0% in K. pneumoniae, 37.0% in P. aeruginosa, and 60.8% in Acinetobacter spp. isolates). Co-resistance to carbapenems and colistin was found in seven (1.6%) GNB isolates. Empiric treatment covered the causative GNB in 63.3% of 215 cases. The in-hospital case fatality ratio was 33.3% (92/276). Pseudomonas aeruginosa species and carbapenem resistance were associated with higher risk of in-hospital death. In conclusion, an important proportion of bloodstream infections in Peru are caused by highly resistant GNB and are associated with high in-hospital mortality.


Assuntos
Infecções por Bactérias Gram-Negativas , Sepse , Humanos , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Escherichia coli , Prevalência , Peru/epidemiologia , Mortalidade Hospitalar , Farmacorresistência Bacteriana , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/epidemiologia , Infecções por Bactérias Gram-Negativas/microbiologia , Carbapenêmicos , Bactérias Gram-Negativas , Klebsiella pneumoniae , Pseudomonas aeruginosa , Sepse/tratamento farmacológico , Testes de Sensibilidade Microbiana
4.
Rev Peru Med Exp Salud Publica ; 39(1): 70-76, 2022.
Artigo em Espanhol, Inglês | MEDLINE | ID: mdl-35766743

RESUMO

A cross-sectional study was carried out on medical students from a private Peruvian university. The aim was to describe knowledge and attitudes towards COVID-19 as well as the student's perception of the role of media outlets and social media. Of the students, 32% did not know that during the first five days of illness, serological tests are preferred for diagnosing COVID-19 over molecular tests; 73% reported being willing to work as a volunteer during the pandemic, and 94% received false information regarding COVID-19 on social media. This study demonstrated that information regarding diagnostic tests should be reinforced and that the high percentage of students willing to volunteer during the COVID-19 pandemic should not be overlooked.


Se realizó un estudio transversal en estudiantes de Medicina de una universidad privada de Lima. El objetivo fue describir el nivel de conocimientos y las actitudes sobre la COVID-19, además de su percepción sobre el rol de los medios de comunicación y de las redes sociales. El 32% no sabía que en los primeros cinco días de la enfermedad, las pruebas serológicas son preferibles para diagnosticar la COVID-19, comparadas con las pruebas moleculares; el 73% reportó estar dispuesto a trabajar como voluntario durante la pandemia y el 94% recibió información falsa sobre la COVID-19 en las redes sociales. Este estudio demuestra que la información sobre el uso de pruebas diagnósticas debe ser reforzada y que se debe tomar en cuenta el alto porcentaje de estudiantes dispuestos a ser voluntarios durante la pandemia de la COVID-19.


Assuntos
COVID-19 , Estudantes de Medicina , COVID-19/diagnóstico , Estudos Transversais , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Pandemias , Percepção , Peru , Inquéritos e Questionários , Universidades
6.
Front Cell Infect Microbiol ; 12: 866186, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35615398

RESUMO

Streptococcus pneumoniae upper respiratory infections and pneumonia are often treated with macrolides, but recently macrolide resistance is becoming an increasingly important problem. The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the National Immunization Program of Peru in 2015. This study aimed to evaluate the temporal evolution of macrolide resistance in S. pneumoniae isolates collected in five cross-sectional studies conducted before and after this vaccine introduction, from 2006 to 2019 in Lima, Peru. A total of 521 and 242 S. pneumoniae isolates recovered from nasopharyngeal swabs from healthy carrier children < 2 years old (2 carriage studies) and samples from normally sterile body areas from pediatric patients with invasive pneumococcal disease (IPD) (3 IPD studies), respectively, were included in this study. Phenotypic macrolide resistance was detected using the Kirby-Bauer method and/or MIC test. We found a significant increase in macrolide resistance over time, from 33.5% to 50.0% in carriage studies, and from 24.8% to 37.5% and 70.8% in IPD studies. Macrolide resistance genes [erm(B) and mef(A/E)] were screened using PCR. In carriage studies, we detected a significant decrease in the frequency of mef(A/E) genes among macrolide-resistant S. pneumoniae strains (from 66.7% to 50.0%) after introduction of PCV13. The most common mechanism of macrolide-resistant among IPD strains was the presence of erm(B) (96.0%, 95.2% and 85.1% in the 3 IPD studies respectively). Macrolide resistance was more common in serotype 19A strains (80% and 90% among carriage and IPD strains, respectively) vs. non-serotype 19A (35.5% and 34.4% among carriage and IPD strains, respectively). In conclusion, S. pneumoniae macrolide resistance rates are very high among Peruvian children. Future studies are needed in order to evaluate macrolide resistance trends among pneumococcal strains, especially now after the COVID-19 pandemic, since azithromycin was vastly used as empiric treatment of COVID-19 in Peru.


Assuntos
COVID-19 , Infecções Pneumocócicas , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Criança , Pré-Escolar , Estudos Transversais , Farmacorresistência Bacteriana , Humanos , Lactente , Macrolídeos/farmacologia , Pandemias , Peru/epidemiologia , Infecções Pneumocócicas/epidemiologia , Infecções Pneumocócicas/prevenção & controle , Vacinas Pneumocócicas , Sorogrupo , Streptococcus pneumoniae , Vacinas Conjugadas
7.
Rev. peru. med. exp. salud publica ; 39(1): 70-76, ene.-mar. 2022. tab
Artigo em Espanhol | LILACS | ID: biblio-1389930

RESUMO

RESUMEN Se realizó un estudio transversal en estudiantes de Medicina de una universidad privada de Lima. El objetivo fue describir el nivel de conocimientos y las actitudes sobre la COVID-19, además de su percepción sobre el rol de los medios de comunicación y de las redes sociales. El 32% no sabía que en los primeros cinco días de la enfermedad, las pruebas serológicas son preferibles para diagnosticar la COVID-19, comparadas con las pruebas moleculares; el 73% reportó estar dispuesto a trabajar como voluntario durante la pandemia y el 94% recibió información falsa sobre la COVID-19 en las redes sociales. Este estudio demuestra que la información sobre el uso de pruebas diagnósticas debe ser reforzada y que se debe tomar en cuenta el alto porcentaje de estudiantes dispuestos a ser voluntarios durante la pandemia de la COVID-19.


ABSTRACT A cross-sectional study was carried out on medical students from a private Peruvian university. The aim was to describe knowledge and attitudes towards COVID-19 as well as the student's perception of the role of media outlets and social media. Of the students, 32% did not know that during the first five days of illness, serological tests are preferred for diagnosing COVID-19 over molecular tests; 73% reported being willing to work as a volunteer during the pandemic, and 94% received false information regarding COVID-19 on social media. This study demonstrated that information regarding diagnostic tests should be reinforced and that the high percentage of students willing to volunteer during the COVID-19 pandemic should not be overlooked.


Assuntos
Estudantes de Medicina , Meios de Comunicação , Conhecimento , COVID-19 , Voluntários , Atitude , Teste Sorológico para COVID-19 , SARS-CoV-2 , Medicina
8.
Rev Peru Med Exp Salud Publica ; 38(2): 313-317, 2021.
Artigo em Espanhol, Inglês | MEDLINE | ID: mdl-34468582

RESUMO

In order to determine the frequency of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolates and to describe the antimicrobial resistance pattern and genotype, a cross-sectional study was conducted in 2017 at the Hospital Nacional Cayetano Heredia in Lima, Peru. We found a MRSA prevalence of 46.1% in the 115 analyzed S. aureus isolates; most were reported from different secretions (26.4%) and blood (18.9%). We found high co-resistance (>75%) to clindamycin, erythromycin, gentamicin and ciprofloxacin. Regarding SSCmec typification, most of the isolates were identified as hospital-acquired MRSA (HA-MRSA) and a minority of them as CA-MRSA (2.6%). Despite its low prevalence when compared to other Latin American countries (27%), epidemiological surveillance is recommended to control local CA-MRSA dissemination.


Con el objetivo de determinar la frecuencia de aislamientos de Staphylococcus aureus meticilinorresistente adquirido en la comunidad (MRSA-AC) y describir el patrón de resistencia antimicrobiana y de genotipo, se realizó un estudio transversal en el 2017 en el Hospital Nacional Cayetano Heredia en Lima, Perú. De los 115 aislamientos de S. aureus analizados, se determinó una frecuencia de MRSA del 46,1%, la mayoría provenientes de secreciones de diferentes tipos (26,4%) y sangre (18,9%). Se encontró alta corresistencia (>75%) a clindamicina, eritromicina, gentamicina y ciprofloxacina entre los aislamientos de MRSA. Según la tipificación de SCCmec, la mayoría correspondían a cepas de MRSA adquirido en un hospital (MRSA-AH) y, solo un pequeño grupo (2,6%) correspondían a MRSA-AC. A pesar de la baja frecuencia descrita con relación a países vecinos (27%), es necesario mantener una adecuada vigilancia epidemiológica local para evitar la propagación local de MRSA-AC.


Assuntos
Infecções Comunitárias Adquiridas , Staphylococcus aureus Resistente à Meticilina , Infecções Estafilocócicas , Antibacterianos/uso terapêutico , Infecções Comunitárias Adquiridas/tratamento farmacológico , Infecções Comunitárias Adquiridas/epidemiologia , Estudos Transversais , Humanos , Staphylococcus aureus Resistente à Meticilina/genética , Testes de Sensibilidade Microbiana , Peru/epidemiologia , Infecções Estafilocócicas/epidemiologia , Staphylococcus aureus , Centros de Atenção Terciária
9.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1508998

RESUMO

Con el objetivo de determinar la frecuencia de aislamientos de Staphylococcus aureus meticilinorresistente adquirido en la comunidad (MRSA-AC) y describir el patrón de resistencia antimicrobiana y de genotipo, se realizó un estudio transversal en el 2017 en el Hospital Nacional Cayetano Heredia en Lima, Perú. De los 115 aislamientos de S. aureus analizados, se determinó una frecuencia de MRSA del 46,1%, la mayoría provenientes de secreciones de diferentes tipos (26,4%) y sangre (18,9%). Se encontró alta corresistencia (>75%) a clindamicina, eritromicina, gentamicina y ciprofloxacina entre los aislamientos de MRSA. Según la tipificación de SCCmec, la mayoría correspondían a cepas de MRSA adquirido en un hospital (MRSA-AH) y, solo un pequeño grupo (2,6%) correspondían a MRSA-AC. A pesar de la baja frecuencia descrita con relación a países vecinos (27%), es necesario mantener una adecuada vigilancia epidemiológica local para evitar la propagación local de MRSA-AC.


In order to determine the frequency of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolates and to describe the antimicrobial resistance pattern and genotype, a cross-sectional study was conducted in 2017 at the Hospital Nacional Cayetano Heredia in Lima, Peru. We found a MRSA prevalence of 46.1% in the 115 analyzed S. aureus isolates; most were reported from different secretions (26.4%) and blood (18.9%). We found high co-resistance (>75%) to clindamycin, erythromycin, gentamicin and ciprofloxacin. Regarding SSCmec typification, most of the isolates were identified as hospital-acquired MRSA (HA-MRSA) and a minority of them as CA-MRSA (2.6%). Despite its low prevalence when compared to other Latin American countries (27%), epidemiological surveillance is recommended to control local CA-MRSA dissemination.

10.
Am J Trop Med Hyg ; 101(4): 746-748, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31392950

RESUMO

Salmonella enterica serovar Infantis is causing an increasing number of infections worldwide. Our aim was to describe the characteristics of S. enterica serovar Infantis among patients attended in a hospital of Lima, Peru. Fifty cases of salmonellosis were seen during October 2015-May 2017; Salmonella Infantis was detected in 36% (n = 18) of them, displacing Enteritidis and Typhimurium (n = 13, 26%, each). Seventeen cases caused by Salmonella Infantis were presented as diarrheal illnesses; only one extraintestinal case (bacteremia) was seen in a 1-year-old infant. This serovar is resistant to multiple groups of antimicrobials, showing only fully susceptibility to carbapenems. Compared with Infantis, other serovars analyzed (mainly Enteritidis and Typhimurium) showed a lower frequency of resistance to antimicrobials such as trimethoprim-sulfamethoxazole, ampicillin, and chloramphenicol. The antibiotic with the highest frequency of resistance was ciprofloxacin. Further studies are needed to evaluate the routes of transmission and measures of control of this multidrug-resistant Salmonella.


Assuntos
Antibacterianos/farmacologia , Bacteriemia/microbiologia , Infecções por Salmonella/microbiologia , Salmonella/imunologia , Adolescente , Bacteriemia/epidemiologia , Bacteriemia/transmissão , Carbapenêmicos/farmacologia , Criança , Pré-Escolar , Ciprofloxacina/farmacologia , Farmacorresistência Bacteriana Múltipla , Hospitais , Humanos , Lactente , Testes de Sensibilidade Microbiana , Peru/epidemiologia , Salmonella/enzimologia , Infecções por Salmonella/epidemiologia , Infecções por Salmonella/transmissão , Salmonella enterica/enzimologia , Salmonella enterica/imunologia , Sorogrupo
11.
PLoS One ; 12(12): e0189946, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29267322

RESUMO

In this study, different molecular typing tools were applied to characterize 95 Salmonella enterica blood isolates collected between 2008 and 2013 from patients at nine public hospitals in Lima, Peru. Combined results of multiplex PCR serotyping, two- and seven-loci multilocus sequence typing (MLST) schemes, serotyping, IS200 amplification and RAPD fingerprints, showed that these infections were caused by eight different serovars: Enteritidis, Typhimurium, Typhi, Choleraesuis, Dublin, Paratyphi A, Paratyphi B and Infantis. Among these, Enteritidis, Typhimurium and Typhi were the most prevalent, representing 45, 36 and 11% of the isolates, respectively. Most isolates (74%) were not resistant to ten primarily used antimicrobial drugs; however, 37% of the strains showed intermediate susceptibility to ciprofloxacin (ISC). Antimicrobial resistance integrons were carried by one Dublin (dfra1 and aadA1) and two Infantis (aadA1) isolates. The two Infantis isolates were multidrug resistant and harbored a large megaplasmid. Amplification of spvC and spvRA regions showed that all Enteritidis (n = 42), Typhimurium (n = 34), Choleraesuis (n = 3) and Dublin (n = 1) isolates carried the Salmonella virulence plasmid (pSV). We conclude that the classic serotyping method can be substituted by the multiplex PCR and, when necessary, sequencing of only one or two loci of the MLST scheme is a valuable tool to confirm the results. The effectiveness and feasibility of different typing tools is discussed.


Assuntos
Bacteriemia/microbiologia , Salmonella enterica/isolamento & purificação , Animais , Humanos , Reação em Cadeia da Polimerase Multiplex , Salmonella enterica/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...